Compare Global X Uranium ETF (URA) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Uranium ETF vs Health Care Select Sector SPDR Fund — how do they compare? Global X Uranium ETF trades at $46.9, while Health Care Select Sector SPDR Fund trades at $166.98. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals.
| URA | XLV | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | — |
52-Week High | $61.81 | $175.68 |
52-Week Low | $37.52 | $134.13 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
URA (Global X Uranium ETF) trades at $47.50, up 3.13% today, with strong bullish technical signals from moving averages. The ETF benefits from growing nuclear energy demand driven by AI power needs and government support, including recent $17.5 billion in U.S. reactor funding. However, key financial ratios remain unavailable, and the sector faces volatility from uranium price fluctuations and regulatory shifts.
Outlook remains positive due to structural tailwinds in nuclear energy, but investors should monitor uranium contract pricing and ETF expense ratios. Near-term resistance sits at $48-$50, with support at $45-$47. Risks include policy changes and miner concentration, though institutional interest in nuclear ETFs is rising.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and steady institutional interest, though recent options activity shows increased put volume. Healthcare sector momentum remains supported by strong earnings and defensive positioning in volatile markets.
Outlook remains cautiously optimistic given healthcare's defensive characteristics and potential Fed rate hike benefits, though near-term technical weakness and sector-specific headwinds like drug trial failures present risks. The ETF's low expense ratio and diversification across 60 healthcare stocks provide stability for long-term investors seeking sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
